Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

National Research Corp (NASDAQ:NRCIB)

40.35
Delayed Data
As of Mar 24
 +0.05 / +0.12%
Today’s Change
32.18
Today|||52-Week Range
46.37
-3.17%
Year-to-Date
NRCIB Regular Dividend: NRCIB will begin trading ex-dividend on 03/29/17 with a $0.60 dividend payable to shareholders of record as of 03/31/17.

Today’s Trading

Previous close40.30
Today’s open40.06
Day’s range40.06 - 40.35
Volume421
Average volume (3 months)1,510
Market cap$142.9M
Dividend yield5.95%
Data as of 12:24pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+15.73%
Earnings growth (this year)+10.84%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+6.88%
P/E ratio13.9
Price/Sales2.69
Price/Book20.53

Competitors

 Today’s
change
Today’s
% change
BIOCBiocept Inc0.000.00%
NRCIANational Research Co...+0.15+0.79%
CEBCEB Inc+0.05+0.06%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$109.4M
Annual profit (last year)$20.3M
Net profit margin18.60%

Profile

Sector
Health Services
Industry
Services to the Health Industry
Chief Executive Officer &
Director
Michael D. Hays
President
Steven D. Jackson
Corporate headquarters
Lincoln, Nebraska

Forecasts


Search for Jobs